Zempsky, William
Bell, John
Mossali, Vanessa Maria
Kachroo, Preeti
Siddiqui, Kamran
Funding for this research was provided by:
GlaxoSmithKline Consumer Healthcare
Article History
Accepted: 19 February 2023
First Online: 16 March 2023
Declarations
:
: This literature analysis was funded by Haleon, Warren, NJ.
: <i>William Zempsky:</i> Consultant for Pfizer, Endo Pharmaceuticals, GlaxoSmithKline, and Vapogenix; funding received from the National Institutes of Health, the US Department of Defense, and the Mayday Fund. <i>John Bell:</i> Consultant for Bayer, GlaxoSmithKline, Mylan, Novartis, Pfizer, and Reckitt Benckiser; speaker for GlaxoSmithKline, Pfizer, and Reckitt Benckiser. <i>Vanessa Maria Mossali:</i> Nothing to disclose. <i>Preeti Kachroo:</i> Employee of Haleon, Singapore. <i>Kamran Siddiqui:</i> Employee of Haleon, Singapore.
: All authors developed the idea for this review article, performed the data analysis, and critically revised the work.
: The references cited in this narrative review are publicly available.
: Not applicable.
: Not applicable.
: Not applicable.